Business Context and Reporting Period
This Form 8-K filing by Novavax, Inc. is dated January 31, 2011. The report addresses a comment letter received from the SEC Division of Corporation Finance on December 21, 2010, regarding the Company's Annual Report on Form 10-K for the year ended December 31, 2009. The Company responded to the SEC on January 21, 2011, proposing specific accounting adjustments and disclosure enhancements.
Key Financial Metrics and Accounting Adjustments
The filing does not report current period revenue, cash flow, or liquidity metrics. Instead, it details the retrospective financial impact of reclassifying warrants issued in July 2008 from stockholders' equity to liabilities. The Company determined that while the warrants were previously classified as equity, they should have been treated as liabilities. The Company concluded that restating prior financial statements would not be material to investors.
| Period | Reported Net Loss (in thousands) | Adjusted Net Loss (in thousands) | Impact on Net Loss | Reported Equity (in thousands) | Adjusted Equity (in thousands) |
|---|---|---|---|---|---|
| Fiscal 2008 | $(36,049) | $(34,578) | $1,471 decrease | $45,489 | $42,814 |
| Fiscal 2009 | $(38,374) | $(40,179) | $(1,805) increase | $74,465 | $69,985 |
| YTD 9/30/2010 | $(31,194) | $(29,790) | $1,404 decrease | $66,993 | $63,917 |
The maximum percentage impact on stockholders' equity was approximately 12.0% in Q2 2009. The maximum percentage impact on net loss was approximately 63.8% in Q2 2009.
Material Changes and Proposals
- Warrant Reclassification: The Company proposed to correct the classification of warrants issued in 2008 as liabilities in its 2010 Form 10-K rather than restating 2008 and 2009 financial statements.
- Disclosure Enhancements: The Company proposed to improve disclosures regarding research and development expenses for major projects and clarify the development phase of these projects in the 2010 Form 10-K.
- Accounting Treatment: The Company acknowledged the error in equity classification but determined the adjustment was not material enough to warrant a restatement of prior periods.
Outlook, Risks, and Contingencies
The SEC Staff has not yet commented on the Company's proposals. There is a risk that the Staff may disagree with the Company's decision not to restate prior financial statements and may require a restatement. The Company expects a response from the SEC in February 2011. The filing notes that the Company will reflect the impact of marking the warrant liability to fair value in the unaudited quarterly financial information footnote of the 2010 Form 10-K.
Investor Verification Checklist
- Verify the SEC's response to the Company's proposal regarding the warrant reclassification, expected in February 2011.
- Confirm whether the SEC requires a restatement of 2008 and 2009 financial statements despite the Company's materiality assessment.
- Review the upcoming 2010 Form 10-K for the proposed enhanced disclosures on R&D expenses and project development phases.
- Monitor the Company's cash position and liquidity, as the filing indicates ongoing net losses but does not provide current cash flow data.